Doma Perpetual Capital Management LLC Pacira Bio Sciences, Inc. Transaction History
Doma Perpetual Capital Management LLC
- $198 Billion
- Q3 2024
A detailed history of Doma Perpetual Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Doma Perpetual Capital Management LLC holds 1,747,849 shares of PCRX stock, worth $33.6 Million. This represents 13.29% of its overall portfolio holdings.
Number of Shares
1,747,849
Previous 1,000,761
74.65%
Holding current value
$33.6 Million
Previous $28.6 Billion
8.13%
% of portfolio
13.29%
Previous 13.28%
Shares
6 transactions
Others Institutions Holding PCRX
# of Institutions
263Shares Held
50.4MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$154 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$102 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$95.3 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$38.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$38 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $880M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...